Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Danish Quality Assurance Project on Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in Outpatient Lung Clinics

This study has been completed.
Sponsor:
Information provided by:
Boehringer Ingelheim
ClinicalTrials.gov Identifier:
NCT00268866
First received: December 22, 2005
Last updated: April 15, 2008
Last verified: April 2008
  Purpose
Danish Quality Assurance Project on Diagnosis and Treatment of COPD in Outpatient Lung Clinics

Condition Intervention Phase
Pulmonary Disease, Chronic Obstructive
Behavioral: Education
Phase 4

Study Type: Observational
Official Title: Danish Quality Assurance Project on Diagnosis and Treatment of COPD in Outpatient Lung Clinics

Resource links provided by NLM:


Further study details as provided by Boehringer Ingelheim:

Primary Outcome Measures:
  • To optimise the diagnosis and treatment of COPD via a quality assurance project
  • Increase the knowledge and use of diagnostic tools and treatment options
  • Increase focus on COPD comorbidity

Estimated Enrollment: 1820
Estimated Study Completion Date: January 2007
Detailed Description:

Study Hypothesis:

Comparison(s):

  Eligibility

Ages Eligible for Study:   35 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Outpatient with the diagnosis or referral diagnosis of COPD.
  • COPD must be the primary reason for this outpatient contact (for both new patients and controls).

Exclusion Criteria:

  • Any co-morbidity that hampers the diagnosis and treatment of COPD in accordance with the COPD guidelines used locally (e.g. malignant disease, dementia or sequelae of apoplexy).
  • Asthma without the presence of COPD
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00268866

Sponsors and Collaborators
Boehringer Ingelheim
Investigators
Study Chair: Boehringer Ingelheim Study Coordinator B.I. Denmark A/S
  More Information

ClinicalTrials.gov Identifier: NCT00268866     History of Changes
Other Study ID Numbers: 205.367 
Study First Received: December 22, 2005
Last Updated: April 15, 2008
Health Authority: Denmark: Danish Dataprotection Agency

Additional relevant MeSH terms:
Lung Diseases
Pulmonary Disease, Chronic Obstructive
Chronic Disease
Respiratory Tract Diseases
Lung Diseases, Obstructive
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on December 07, 2016